Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

343
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
343
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

409
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
409
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

398
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
398
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

584
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
584
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

543
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
543

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective decreases in regulatory B cell (Breg) subsets in active uveitis: IL-10+CD19+CD24hiCD38hiBreg in patients and B10 Breg in mice.

International immunology·2026
Same author

Adalimumab biosimilars have similar efficacy to originator adalimumab when treating non-infectious uveitis.

The British journal of ophthalmology·2025
Same author

Impact of microorganism virulence on endophthalmitis outcomes.

The British journal of ophthalmology·2024
Same author

Mechanisms of blood-retinal barrier disruption related to intraocular inflammation and malignancy.

Progress in retinal and eye research·2024
Same author

Can Simvastatin Reduce the Need for Immunomodulatory Drugs to Treat Uveitis?: A Prospective, Randomized, Placebo-Controlled Trial.

Ophthalmology science·2023
Same author

Comparison of anatomical and functional outcomes of treating myopic choroidal neovascularization with bevacizumab or ranibizumab.

International ophthalmology·2023
Same journal

Comparative Visual Outcomes of Toric and Nontoric Intraocular Lenses Featuring Combined Diffractive Extended Depth of Focus and Multifocal Designs.

Journal of ophthalmology·2026
Same journal

Prognostic Value of Interocular Flicker ERG Asymmetry in Acute Postoperative Endophthalmitis After Intraocular Surgery: A Pilot Study.

Journal of ophthalmology·2026
Same journal

Clinical Ophthalmology Consultations in Paediatric Inpatient Rehabilitation-A Retrospective Case-Note Analysis.

Journal of ophthalmology·2026
Same journal

Pathogenesis of Neovascular Glaucoma in Diabetic Retinopathy: A Review.

Journal of ophthalmology·2026
Same journal

Mathematical Modeling of IOL Power Changes After Pupil Dilation Based on Multifactorial Analysis.

Journal of ophthalmology·2026
Same journal

Reduced Neutrophil-to-Eosinophil Ratio in Chronic Dacryocystitis: A Hematological Clue to Allergic Pathogenesis.

Journal of ophthalmology·2026
See all related articles

Related Experiment Video

Updated: Apr 29, 2026

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
09:28

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

8.3K

Ischemic retinal vasculitis and its management.

Lazha Talat1, Sue Lightman1, Oren Tomkins-Netzer1

  • 1Moorfields Eye Hospital, City Road, London EC1V 2PD, UK ; UCL Institute of Ophthalmology, London EC1V 9EL, UK.

Journal of Ophthalmology
|May 20, 2014
PubMed
Summary
This summary is machine-generated.

Ischemic retinal vasculitis, an inflammation of retinal blood vessels, can cause vision loss. Current treatments include corticosteroids, laser photocoagulation, and biologics, but long-term effects require further study.

More Related Videos

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina
07:32

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina

Published on: June 23, 2014

13.6K
In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility
07:35

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

Published on: April 21, 2022

2.1K

Related Experiment Videos

Last Updated: Apr 29, 2026

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
09:28

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

8.3K
Assessment of Vascular Regeneration in the CNS Using the Mouse Retina
07:32

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina

Published on: June 23, 2014

13.6K
In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility
07:35

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

Published on: April 21, 2022

2.1K

Area of Science:

  • Ophthalmology
  • Vascular Biology
  • Immunology

Background:

  • Ischemic retinal vasculitis involves retinal blood vessel inflammation, occlusion, and hypoperfusion.
  • It leads to vision loss through complications like macular ischemia, edema, neovascularization, and retinal detachment.
  • Causes can be idiopathic or secondary to systemic diseases (e.g., Behçet's, sarcoidosis, MS, SLE).

Purpose of the Study:

  • To review the current understanding of ischemic retinal vasculitis.
  • To discuss established and emerging treatment strategies.
  • To highlight areas needing further research, particularly long-term outcomes.

Main Methods:

  • Literature review of ischemic retinal vasculitis.
  • Analysis of treatment modalities including corticosteroids, laser photocoagulation, bevacizumab, anti-TNF agents, and interferon.
  • Discussion of disease associations and complications.

Main Results:

  • Corticosteroids and laser photocoagulation are primary treatments.
  • Intravitreal bevacizumab is used for neovascularization in SLE, requiring careful timing with laser.
  • Anti-TNF agents show promise for refractory cases (except MS), and interferon aids in Behçet's and MS.
  • Long-term efficacy of these strategies remains under investigation.

Conclusions:

  • Effective management of ischemic retinal vasculitis involves a combination of therapies tailored to the underlying cause.
  • Further research is essential to understand the long-term impact of current treatments on preventing disease progression and preserving vision.
  • The role of newer agents like anti-TNF therapy warrants continued investigation in refractory cases.